4 results match your criteria: "NHO Utano National Hospital.[Affiliation]"
Treatment for paraneoplastic neuromyelitis optica spectrum disorder (NMOsd): Probable effects of tocilizumab for both cancer and NMOsd.
Mult Scler Relat Disord
February 2018
Department of Neurology, Kaikoukai Josai Hospital, 1-4 Kitabatake, Nakamura-Ku, Nagoya 453-0815, Japan.
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Mult Scler
September 2016
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Background: No large-scale studies have compared the efficacy of intravenous methylprednisolone pulse therapy (IVMP) for multiple sclerosis (MS) and neuromyelitis optica (NMO).
Objective: To explain differences in treatment responses of MS and NMO patients to IVMP.
Methods: Changes in neurological symptoms/signs and Expanded Disability Status Scale (EDSS) scores before and within 1 week of IVMP completion were obtained in 2010 at 28 institutions, and retrospectively collated from 271 MS (478 courses) and 73 NMO (118 courses) cases.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
Nihon Naika Gakkai Zasshi
August 2013
Multiple Sclerosis Center, NHO Utano National Hospital, Japan.
[Brain MRI findings in Japanese patients with clinically isolated syndrome].
Rinsho Shinkeigaku
November 2013
Multiple Sclerosis Center, NHO Utano National Hospital.
Treatment of patients with clinically isolated syndrome (CIS) with disease modifying drugs including interferon β delays conversion to clinically definite multiple sclerosis (MS). However, CIS patients do not necessarily develop MS even after 20 years. Brain MRI lesions were required for CIS patients to include in clinical trials such as CHAMPS study and BENEFIT study.
View Article and Find Full Text PDF